$13.20
▼ $0.02 (-0.2%)
ENTA
Enanta Pharmaceuticals, Inc.
Health Care
Investor Score
51C-
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
68
Technical
30
Fundamental
68
Growth
43
Fair Value
50
News
42
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.